A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia

Clinical trial NCT04358432 · COMPLETED

Trial details

NCT number: NCT04358432
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2020-05-13
Primary completion: 2021-02-25
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.